ICAM1 and Alzheimer disease: CSF ICAM-1 levels showed a positive correlation with increased risk of developing AD (Janelidze et al., 2018) and post-mortem tissue studies have shown increased ICAM-1 expression in areas with AD pathology (Akiyama et al., 1993).